| 000 | 01632 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250516030820.0 | ||
| 264 | 0 | _c20110930 | |
| 008 | 201109s 0 0 eng d | ||
| 022 | _a1879-0720 | ||
| 024 | 7 |
_a10.1016/j.ejps.2011.03.004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGiordani, Antonio | |
| 245 | 0 | 0 |
_aOverall impact of the regulatory requirements for genotoxic impurities on the drug development process. _h[electronic resource] |
| 260 |
_bEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences _cMay 2011 |
||
| 300 |
_a1-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aDNA Damage |
| 650 | 0 | 4 |
_aDrug Contamination _xlegislation & jurisprudence |
| 650 | 0 | 4 |
_aDrug Industry _xstandards |
| 650 | 0 | 4 | _aEurope |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInternational Cooperation |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aMutagens _xanalysis |
| 650 | 0 | 4 |
_aPharmaceutical Preparations _xanalysis |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aToxicity Tests _xstandards |
| 650 | 0 | 4 | _aUnited States |
| 650 | 0 | 4 | _aUnited States Food and Drug Administration |
| 700 | 1 | _aKobel, Werner | |
| 700 | 1 | _aGally, Hans Ulrich | |
| 773 | 0 |
_tEuropean journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences _gvol. 43 _gno. 1-2 _gp. 1-15 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ejps.2011.03.004 _zAvailable from publisher's website |
| 999 |
_c20690945 _d20690945 |
||